AG
SLDB icon

Algert Global’s Solid Biosciences SLDB Stock Holding History

Algert Global’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
187,419
+114,765
+158% +$870K 0.02% 852
2026
Q1 		$523K Buy
+72,654
New +$467K 0.01% 961
2025
Q1 		– Sell
-22,089
Closed -$88.4K – 1317
2024
Q4 		$88.4K Buy
22,089
+6,930
+46% +$38.1K ﹤0.01% 1126
2024
Q3 		$106K Buy
15,159
+680
+5% +$5.51K ﹤0.01% 1109
2024
Q2 		$82.1K Buy
+14,479
New +$130K ﹤0.01% 1410
2022
Q3 		– Sell
-3,272
Closed -$30K – 1325
2022
Q2 		$30K Sell
3,272
-2,950
-47% -$30.7K ﹤0.01% 1169
2022
Q1 		$112K Sell
6,222
-2,854
-31% -$50.4K 0.01% 1101
2021
Q4 		$238K Buy
9,076
+6,064
+201% +$185K 0.03% 803
2021
Q3 		$108K Buy
3,012
+586
+24% +$24.9K 0.01% 963
2021
Q2 		$133K Buy
2,426
+1,504
+163% +$99.4K 0.04% 383
2021
Q1 		$76K Buy
+922
New +$102K 0.02% 417

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Algert Global's SLDB Position: Q2 2026 in Review

Algert Global increased its Solid Biosciences (SLDB) stake by 158% in Q2 2026, buying an estimated $870K and bringing the position to 187,419 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #852.

Algert Global first reported a position in SLDB in Q1 2021 and has held it in 11 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Algert Global held 187,419 shares of Solid Biosciences worth $1.87M as of Q2 2026.
  • Algert Global bought 114,765 Solid Biosciences shares in Q2 2026, an estimated $870K.
  • Solid Biosciences made up 0.02% of Algert Global's portfolio in Q2 2026, its #852 holding.
  • Algert Global first reported a position in Solid Biosciences in Q1 2021 and has held it in 11 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.